Top Markets
Coin of the day
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD

Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD

300534
株式のランク #11765
Gansu Longshenrongfa Pharmaceutical Industry Co.,Ltd operates as a... Gansu Longshenrongfa Pharmaceutical Industry Co.,Ltd operates as a pharmaceutical enterprise, focusing on the research, development, manufacturing, and commercialization of traditional Chinese medicines, health supplements, and active pharmaceutical ingredients (APIs). Its extensive product line includes therapeutic remedies such as Yuanhu Analgesic dropping pills, Qiwei Wenyang capsules, Maxing cough capsules, Shuxinning tablets, Panax notoginseng pills, Anti-inflammatory and gallbladder tablets, Children's Qingfei cough tablets, Pediatric Qinggan tablets, Suanzaoren oil dropping pills, Xiaoshuan Tongluo tablets, Xiaoyanlidan tablets, Compound Danshen tablets, Astragalus Angelica capsules, and berberine tannin films. Beyond its core manufacturing, the company is actively involved in the cultivation, procurement, processing, and distribution of Chinese medicinal raw materials. Its operations further encompass project investment and management, alongside the import, sale, logistics, and export of pharmaceutical goods. Established in 2002, Gansu Longshenrongfa Pharmaceutical Industry Co.,Ltd is headquartered in Lanzhou, China.
株価
$2.18
最終同期: 2026-08-28
時価総額
$661.58M
変化(1日)
-13.01%
変化(1年)
52.92%
CN
取引 Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD (300534)

カテゴリー

Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD(300534)のEPS
2026 時点のEPS TTM: 0
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTDの最新の財務報告と株価によると、同社の現在のEPS(TTM)は0です。2026年末には、EPSは0で、2026年のEPS0と同等でした。
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTDのEPS履歴(2026から2026まで)
各年末時点のEPS
EPS 変化
提供された日付のデータは十分ではありません。